Adaptin Bio APTN Growth Metrics (2023-2026)

OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT
Reported Financials

Adaptin Bio Quarterly Growth Metrics

Periods 11 quarters
Latest Jun 2026

Adaptin Bio reported asset growth of -40.97% for the quarter ended Jun 2026. These growth metrics cover 11 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y) -24.00%-15.26%62,903.95%750,953.68%516,246.27%304,084.47%158.61%-75.26%-40.97%
Assets Growth (3y) 973.85%
Assets (QoQ) 0.00%0.00%-15.26%0.00%74,252.48%1,092.07%-41.74%-41.09%-36.79%14.04%38.99%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 850.80%-15.26%616.98%46,830.80%5,584.38%179,741.30%1,247.14%-87.31%-50.39%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) 872.01%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) 1,151.05%6.42%369.97%-98.65%10,485.40%6,865.61%-43.08%-57.15%-20.71%-34.38%122.53%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) 293.07%-2,441.81%-401.76%-64.90%-723.93%73.85%55.98%
Cash from Operations (QoQ)Cash from Ops. (QoQ) -53.73%-127.24%-129.81%124.05%-2,123.80%55.14%24.47%9.00%15.16%24.51%
EBIT Growth (1y) -2,216.71%-1,387.57%-183.74%-98.20%-68.45%-169.25%-34.53%21.06%
EBIT (QoQ) 20.46%-777.58%-156.00%-29.64%48.92%-67.39%-78.83%-10.18%18.36%16.36%-4.93%
EBT Growth (1y) -2,479.42%-2,408.67%-77.67%-85.76%-51.29%-63.44%-90.04%20.75%
EBT (QoQ) 20.46%-893.80%-141.21%-35.28%22.64%29.62%-152.18%-10.18%16.42%18.16%-5.17%
EPS (Basic) Growth (1y) -2,479.42%-2,408.67%-52.46%-9.85%10.54%-4.61%-27.26%24.28%
EPS (Basic) (QoQ) 20.46%-893.80%-141.21%-35.28%22.64%39.60%-73.81%-10.16%9.54%26.53%-3.41%
EPS (Diluted) Growth (1y) -2,479.42%-2,408.67%-52.46%-9.85%10.54%-4.61%-27.26%24.28%
EPS (Diluted) (QoQ) 20.46%-893.80%-141.21%-35.28%22.64%39.60%-73.81%-10.16%9.54%26.53%-3.41%
Free Cash Flow Growth (1y)FCF Growth (1y) 293.07%-2,441.81%-401.76%-64.90%-723.93%73.85%55.98%
Free Cash Flow (QoQ)FCF (QoQ) -53.73%-127.24%-129.81%124.05%-2,123.80%55.14%24.47%9.00%15.16%24.51%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) -54.49%-4,930.93%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) -106.51%40.33%62.69%-236.08%56.58%
Net Cash Flow Growth (1y)NCF Growth (1y) 767,160.33%-5,564.07%-943.89%-47.64%-106.75%136.10%
Net Cash Flow (QoQ)NCF (QoQ) 6,036.72%389.03%-188.74%2,981.13%-143.70%24.47%84.48%-31.65%333.86%
Net Income Growth (1y) -2,479.42%-2,408.67%-77.67%-85.76%-51.29%-63.44%-90.04%20.75%
Net Income (QoQ) 20.46%-893.80%-141.21%-35.28%22.64%29.62%-152.18%-10.18%16.42%18.16%-5.17%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -2,479.42%-2,408.67%-77.67%-85.76%-51.29%-63.44%-90.04%20.75%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) 20.46%-893.80%-141.21%-35.28%22.64%29.62%-152.18%-10.18%16.42%18.16%-5.17%
Operating Income Growth (1y)Op. Inc Growth (1y) -2,216.71%-1,387.57%-183.74%-98.20%-68.45%-169.25%-34.53%21.06%
Operating Income (QoQ)Op. Inc (QoQ) 20.46%-777.58%-156.00%-29.64%48.92%-67.39%-78.83%-10.18%18.36%16.36%-4.93%
Profit After Tax Growth (1y)PAT Growth (1y) -2,479.42%-2,408.67%-77.67%-85.76%-51.29%-59.66%-90.04%20.75%
Profit After Tax (QoQ)PAT (QoQ) 20.46%-893.80%-141.21%-35.28%22.64%29.62%-152.18%-10.18%18.36%16.22%-5.17%
Return on Assets [ROA] Growth (1y)ROA Growth (1y) 35.17M71.39M0.20M-0.06M-0.05M
Return on Assets [ROA] (QoQ)ROA (QoQ) -36.23M71.16M0.24M0.00M-0.02M-0.03M-0.02M0.02M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) -0.09M-0.00M0.04M0.10M0.07M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 0.03M-0.08M-0.08M0.04M0.12M-0.04M-0.01M-0.00M
Share-based Compensation (QoQ)Stock Comp. (QoQ) -105.25%2,070.67%55.27%
Total Debt Growth (1y) 2,962.56%303.05%1,004.22%
Total Debt (QoQ) 287.94%0.00%-13.46%20.06%962.82%-32.61%